# The Safety and Efficacy of AVI Stent for Treating Coronary Revascularization

Study · id `cardio:ct-nct02117843` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02117843](<https://clinicaltrials.gov/study/NCT02117843>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02117843

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT02117843. Allocation not applicable; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT02117843, source copy `cardio:ctgov-nct02117843-2017-06-27`, retrieved 2026-10-31)
- Start date: 2013-07 (registry gives no type) (ClinicalTrials.gov record NCT02117843, source copy `cardio:ctgov-nct02117843-2017-06-27`, retrieved 2026-10-31)
- Primary completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02117843, source copy `cardio:ctgov-nct02117843-2017-06-27`, retrieved 2026-10-31)
- Completion: 2021-04 (anticipated) (ClinicalTrials.gov record NCT02117843, source copy `cardio:ctgov-nct02117843-2017-06-27`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02117843, source copy `cardio:ctgov-nct02117843-2017-06-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02117843-2017-06-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization
- Condition: Ischemic Heart Disease
- Condition: Myocardial Ischemia
- Condition: Coronary Disease
- Condition: Acute Coronary Syndrome
- Intervention (Device): AVI® Arsenic trioxide drug eluting stent
- Lead sponsor: Beijing AmsinoMed Medical Device Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

## Provenance

Content hash: 885ab549eda114fea1d85337bb3d4cd564359b30829e2f799c77f99491e6a83f
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
